Business Context and Reporting Period
This Form 8-K filing by SRx Health Solutions, Inc. (SRXH) covers the event date of January 6, 2026. The Company is incorporated in Delaware and its common stock trades on the NYSE American. The report addresses a critical regulatory matter regarding the Company's continued listing status.
Key Financial Metrics
The filing provides specific historical financial data related to listing compliance standards but does not report current period revenue, profit, or cash flow.
- Stockholders' Equity: Reported at ($45.9) million as of June 30, 2025.
- Profitability Status: The Company reported losses from continuing operations and/or net losses in three of its four most recent fiscal years ended December 31, 2024.
- Listing Standard Threshold: The NYSE American requires listed companies with such loss histories to maintain stockholders' equity of at least $4 million.
Material Changes and Listing Status
On October 14, 2025, the NYSE American notified the Company that it failed to meet the continued listing standard due to negative stockholders' equity and recurring losses. On January 6, 2026, the NYSE American accepted the Company's plan to regain compliance with Sections 1003(a)(i) and (ii) of the Company Guide. Consequently, the Company's listing has been continued under an extension.
Guidance, Outlook, and Risks
Compliance Plan: The Company has a targeted completion date of July 14, 2026, to regain full compliance. It is required to provide quarterly updates to the NYSE American regarding its progress.
Risks and Contingencies: The filing includes a cautionary note regarding forward-looking statements. Risks include regulatory environment changes, litigation, and general economic conditions. Failure to meet the compliance plan by the targeted date could result in delisting.
Investor Verification Checklist
- Verify the specific initiatives outlined in the Company's plan to increase stockholders' equity to the $4 million threshold.
- Monitor quarterly updates to the NYSE American for progress toward the July 14, 2026, deadline.
- Review the most recent Form 10-K and 10-Q filings for detailed financial statements and risk factors not fully elaborated in this 8-K.
- Confirm the status of the press release dated January 8, 2026, referenced as Exhibit 99.1.